- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07483606
Turkish Validity and Reliability Study of PRevention of Toxic Chemicals in the Environment for Children Tool
March 16, 2026 updated by: Rukiye Duman, Istanbul University - Cerrahpasa
Turkish Validity and Reliability Study of PRevention of Toxic Chemicals in the Environment for Children Tool (PRoTECT)
The aim of this study is to conduct a Turkish validity and reliability study of the "Prevention of Toxic Chemicals in the Environment for Children Tool," developed to examine the knowledge and attitudes of parents and prospective parents regarding the effects of toxic chemicals in the environment on children's development.
Study Overview
Status
Recruiting
Study Type
Observational
Enrollment (Estimated)
204
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: RUKİYE DUMAN RESEARCH ASSISTANT
- Phone Number: +90 5530315895
- Email: rukiye.duman@iuc.edu.tr
Study Locations
-
-
AVCILAR
-
Istanbul, AVCILAR, Turkey (Türkiye), 34310
- Recruiting
- Rukiye Duman
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Probability Sample
Study Population
The research population will consist of parents or prospective parents.
Literature indicates that in methodological research, the sample size required to test the validity and reliability of measurement instruments should be 10-15 times the number of items in the scale (Esin, 2024).
Accordingly, in this research, the minimum required sample size was planned as 12 times the number of items in the measurement instrument (17 x 12 = 204), based on this rule.
Description
Inclusion Criteria:
Adult parents and prospective parents
Exclusion Criteria:
Illiterate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
"Prevention of Toxic Chemicals in the Environment for Children Tool" Turkish validity and reliability
Time Frame: 1 months
|
"To conduct the Turkish validity and reliability study of the 'Prevention of Toxic Chemicals in the Environment for Children Tool'."
|
1 months
|
|
The Relationship Between Knowledge and Attitudes Towards Prevention of Toxic Chemicals in the Environment for Children and Environmental Literacy
Time Frame: 1 months
|
The study also examines the relationship between parents' and prospective parents' knowledge and attitudes towards toxic chemicals in the environment that negatively affect child development and their environmental literacy.
|
1 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
March 16, 2026
Primary Completion (Estimated)
April 3, 2026
Study Completion (Estimated)
May 4, 2026
Study Registration Dates
First Submitted
March 16, 2026
First Submitted That Met QC Criteria
March 16, 2026
First Posted (Actual)
March 19, 2026
Study Record Updates
Last Update Posted (Actual)
March 19, 2026
Last Update Submitted That Met QC Criteria
March 16, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- IstanbulUC-EBE-RD-03
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Adult Participants
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Not yet recruitingHealthy Participants | Healthy Adult ParticipantsUnited States
-
University of PalermoCompletedHealthy Participants | Healthy Adult Participants | Healthy Young AdultsItaly
-
Universidad San SebastiánAgencia Nacional de Investigación y DesarrolloNot yet recruitingHealthy | Healthy Adult ParticipantsChile
-
Dragonfly TherapeuticsRecruitingHealthy | Healthy Participants | Healthy Adult Females | Volunteer | Healthy Adult MaleAustralia
-
Umm Al-Qura UniversityActive, not recruitingHealthy | Healthy Participants | Healthy Adult | Healthy Women | Healthy Adult Females | Healthy Adult Participants | Healthy Young Adults | Healthy Adult Female Participants | Healthy Adult Male | Poor Sleep Quality | Healthy (Controls) | Poor Sleeping Quality | Healthy Adult Male Subjects | Health Adult SubjectsSaudi Arabia
-
Poznan University of Physical EducationNot yet recruitingHealthy Adult Participants
-
BioVersys SASRecruiting
-
NeuHyll AUS Pty LtdNeuHyll Therapeutics IncNot yet recruiting
-
Cairo UniversityNot yet recruitingHealthy Adult ParticipantsEgypt
-
Chengdu Kanghong Pharmaceutical Group Co., Ltd.Not yet recruitingHealthy Adult Participants